Taiwan Journal of Ophthalmology最新文献_第5页

Comparative evaluation of “closed posterior levator advancement” in simple congenital and aponeurotic ptosis 单纯性先天性上睑下垂和肌腱膜性上睑下垂的 "闭合性后上睑提肌腱膜前移术 "比较评估

IF 1.1

Taiwan Journal of Ophthalmology Pub Date : 2024-01-05 DOI: 10.4103/tjo.tjo-d-23-00081

R. Goel, Sonam Singh, Shalin Shah, S. Khanam, Priyanka Golhait, Tanvi Gaonker

{"title":"Comparative evaluation of “closed posterior levator advancement” in simple congenital and aponeurotic ptosis","authors":"R. Goel, Sonam Singh, Shalin Shah, S. Khanam, Priyanka Golhait, Tanvi Gaonker","doi":"10.4103/tjo.tjo-d-23-00081","DOIUrl":"https://doi.org/10.4103/tjo.tjo-d-23-00081","url":null,"abstract":"\u0000 \u0000 \u0000 The purpose of this study was to compare the outcomes of “closed posterior levator advancement” (CPLA) in acquired aponeurotic and simple congenital ptosis with good levator function (LF).\u0000 \u0000 \u0000 \u0000 A prospective interventional study was conducted on 20 adult patients, 10 simple congenital ptosis, and 10 acquired aponeurotic ptosis with LF ≥8 mm. Complicated, posttraumatic, neurogenic ptosis and previous lid surgery were excluded. A detailed history and assessment of visual acuity, upper eyelid margin reflex distance (MRD1), margin-crease distance, LF, Bell’s phenomenon, ocular surface disease index (OSDI), and phenylephrine test were undertaken. CPLA was performed in the 20 eyes and were followed up for 3 months.\u0000 \u0000 \u0000 \u0000 The ages of the study participants ranged from 18 to 64 years, and the male: female ratio was 11:9. There were nine aponeurotic and one congenital severe ptosis, the remaining 10 being mild–moderate ptosis. The etiologies in the aponeurotic group were involutional (2), contact lens wear (1), allergic conjunctivitis (3), and idiopathic in four eyes. The success rates were 90% in both groups. The amount of ptosis correction showed a positive relation with LF (r\u0000 s = 0.6, P = 0.004) and phenylephrine test (r\u0000 s = 0.7, P < 0.001). The complications in the aponeurotic group were lagophthalmos (2/10), subjective dry eye (2/10), subconjunctival hemorrhage (1/10), symblepharon (1/10), temporal flare (1/10), and overcorrection (1/10). The congenital group showed only undercorrection (1/10).\u0000 \u0000 \u0000 \u0000 CPLA is an effective procedure for the treatment of mild–moderate simple congenital and all grades of aponeurotic ptosis with good LF. Response to phenylephrine test serves as a useful guide to the amount of ptosis correction.\u0000","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139449956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Extraocular muscle bridle traction suture assisted Paul glaucoma implant surgery for severe conjunctival scarring 眼外肌桥牵引缝合辅助保罗青光眼植入手术治疗严重结膜瘢痕

IF 1.1

Taiwan Journal of Ophthalmology Pub Date : 2024-01-05 DOI: 10.4103/tjo.tjo-d-23-00118

Yi-Ching Shao, Lu-Chun Wang, Yi-An Lee

引用次数: 0

Bilateral optic neuritis and encephalopathy as the atypical presentations of multiple sclerosis following severe acute respiratory syndrome coronavirus 2 infection 双侧视神经炎和脑病是严重急性呼吸系统综合征冠状病毒 2 感染后多发性硬化症的非典型表现

IF 1.1

Taiwan Journal of Ophthalmology Pub Date : 2024-01-05 DOI: 10.4103/tjo.tjo-d-23-00124

Sheng-Yu Liu, Wan-Jen Hsieh, Hsueh-Wen Hsueh, Chao-Wen Lin

{"title":"Bilateral optic neuritis and encephalopathy as the atypical presentations of multiple sclerosis following severe acute respiratory syndrome coronavirus 2 infection","authors":"Sheng-Yu Liu, Wan-Jen Hsieh, Hsueh-Wen Hsueh, Chao-Wen Lin","doi":"10.4103/tjo.tjo-d-23-00124","DOIUrl":"https://doi.org/10.4103/tjo.tjo-d-23-00124","url":null,"abstract":"\u0000 Numerous evidence suggests coronavirus disease 2019 (COVID-19) potentially triggers demyelinating diseases, inclusive of multiple sclerosis (MS), and acute disseminated encephalomyelitis (ADEM), and various mechanisms have been proposed. We report a 42-year-old male presented with bilateral optic neuritis and encephalopathy, 2 weeks following COVID-19 infection. He denied any history or family history of neurological and ocular diseases. Severe bilateral visual impairment (only light perception) and pain with eye movement were reported. Fundoscopy revealed bilateral optic disc swelling. Magnetic resonance imaging showed tortuous bilateral optic nerves with optic nerve and nerve sheath enhancement. Multiple hyperintense nodules in bilateral cerebral white matter were noted on fluid-attenuated inversion recovery T2-weighted imaging without diffusion restriction or gadolinium contrast enhancement. Hypointense nodules in cerebral white matter were also noted on T1-weighted imaging, which implied some old lesions. Dissemination in space and time and cerebrospinal fluid-specific oligoclonal bands confirmed the diagnosis of MS. Both serum aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies were negative. He received pulse steroid therapy for 5 days, followed by slowly tapering oral prednisolone. His vision, ocular motion pain, and encephalopathy improved gradually. However, the visual outcome was still poor (bilateral 20/400), and optic atrophy was noticed during 1-year follow-up. To our knowledge, this is the first case of MS following severe acute respiratory syndrome coronavirus 2 infection presented with bilateral optic neuritis and encephalopathy. Since these manifestations are exceedingly rare in MS, we suspect acute immune reactions induced by COVID-19 could bring about the atypical ADEM-like presentations of MS.","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139450032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Aflibercept treatment for delayed retinotomy-associated choroidal neovascularization: A case report and literature review Aflibercept治疗延迟视网膜切除术相关脉络膜新生血管：病例报告和文献综述

IF 1.1

Taiwan Journal of Ophthalmology Pub Date : 2024-01-05 DOI: 10.4103/tjo.tjo-d-23-00072

Cyuan-Yi Yeh, Yi-Ting Liang, Cheng-Kuo Cheng

{"title":"Aflibercept treatment for delayed retinotomy-associated choroidal neovascularization: A case report and literature review","authors":"Cyuan-Yi Yeh, Yi-Ting Liang, Cheng-Kuo Cheng","doi":"10.4103/tjo.tjo-d-23-00072","DOIUrl":"https://doi.org/10.4103/tjo.tjo-d-23-00072","url":null,"abstract":"\u0000 A 67-year-old male presented to our clinic with sudden onset of blurred vision and metamorphopsia of his left eye for 2 weeks. He had a history of combined rhegmatogenous retinal detachment and vitreous hemorrhage and underwent an uneventful pars plana vitrectomy, 360° scleral buckling, and drainage retinotomy for his left eye 3 years ago. The anatomic and visual outcomes after surgery were good, without complications. On examination during this visit, an orange–red subretinal mass connected to the previous drainage retinotomy scar was noted. Spectral-domain optical coherence tomography revealed severe subretinal fluid with type-2 choroidal neovascularization (CNV) mass at the superior nasal macular area in connection with the margin of the previous retinotomy scar. Fundus fluorescein angiography showed an active CNV. The patient underwent monthly intravitreal aflibercept in the left eye. After four doses of aflibercept, his CNV regressed with no recurrence on follow-up at 20 months. In conclusion, iatrogenic CNV is a rare complication following uneventful vitreoretinal surgery and can develop years after the operation. It is crucial to early diagnose and treat it with intravitreal antivascular endothelial growth factor treatment for a favorable outcome and long-term remission.","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139450377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comparison of the efficacy of micropulse diode laser transscleral cyclophotocoagulation using different energy protocols 采用不同能量方案的微脉冲二极管激光经巩膜环形光凝术的疗效比较

IF 1.1

Taiwan Journal of Ophthalmology Pub Date : 2024-01-05 DOI: 10.4103/tjo.tjo-d-23-00129

Kuan-Yu Chen, Shirley H. L. Chang

{"title":"Comparison of the efficacy of micropulse diode laser transscleral cyclophotocoagulation using different energy protocols","authors":"Kuan-Yu Chen, Shirley H. L. Chang","doi":"10.4103/tjo.tjo-d-23-00129","DOIUrl":"https://doi.org/10.4103/tjo.tjo-d-23-00129","url":null,"abstract":"\u0000 \u0000 \u0000 This study aimed to explore the safety and efficacy of laser treatment settings of micropulse transscleral cyclophotocoagulation treatment in glaucoma patients and to evaluate the relationship between intraocular pressure (IOP) reduction and different treatment parameters.\u0000 \u0000 \u0000 \u0000 A total of 74 eyes in 64 glaucoma patients with IOP over 21 mmHg or under 20 mmHg with visual field progression who underwent micropulse transscleral cyclophotocoagulation treatment were included. Patients were divided into success and failure groups based on criteria of 20% IOP reduction rate. The predictive factors of IOP reduction between success and failure groups and the IOP reduction rates in the different treatment duration groups were evaluated. Predictive factors for IOP reduction were analyzed using univariate and multivariate regression models.\u0000 \u0000 \u0000 \u0000 Patients in the success group had significantly higher baseline IOP (median: 28.0 vs. 23.0 mmHg; P = 0.016) and longer treatment times (median: 240 vs. 160 s; P = 0.001). Treatment duration range between 200 and 240 s achieved significantly higher intraocular pressure reduction rates (47.8 ± 17.4%) than durations under 140 s (23.1 ± 14.2%). Univariate analysis showed that baseline IOP and treatment duration were significant contributing factors in IOP reduction. Multivariable analysis further demonstrated that treatment duration over 200 s was the significant predictive factor for IOP reduction.\u0000 \u0000 \u0000 \u0000 Treatment duration settings were the most significant factor of IOP reduction rates in micropulse cyclophotocoagulation. Customized therapy according to the target IOP reduction rate can be applied with different treatment duration settings to achieve optimal outcomes.\u0000","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139450093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Therapeutic future of Fuchs endothelial corneal dystrophy: An ongoing way to explore 福氏内皮角膜营养不良症的治疗前景：不断探索

IF 1.1

Taiwan Journal of Ophthalmology Pub Date : 2024-01-05 DOI: 10.4103/tjo.tjo-d-23-00115

Jia-Xin Liu, Tung-Lin Chiang, Kai-Feng Hung, Yi-Chen Sun

{"title":"Therapeutic future of Fuchs endothelial corneal dystrophy: An ongoing way to explore","authors":"Jia-Xin Liu, Tung-Lin Chiang, Kai-Feng Hung, Yi-Chen Sun","doi":"10.4103/tjo.tjo-d-23-00115","DOIUrl":"https://doi.org/10.4103/tjo.tjo-d-23-00115","url":null,"abstract":"\u0000 Fuchs endothelial corneal dystrophy (FECD) is one of the most common corneal diseases that causes loss of visual acuity in the world. FECD is a genetically and pathogenetically heterogeneous disease that results in the failure of corneal endothelial cells to maintain fluid balance and functional homeostasis of the cornea. Corneal edema, central guttae formation, and bullae development are common corneal pathologies. Currently, the mainstay of FECD treatment is surgery. However, limited sources of corneal graft and postsurgical complications remain problematic. In recent years, with advances in medical science and technology, there have been a few promising trials of new treatment modalities for FECD. In addition to new surgical methods, novel modalities can be classified into pharmacological-associated treatment, cell therapy-associated treatment, and gene therapy-associated treatment. In this article, our primary focus is on the most recent clinical trials related to FECD, and we present a stepwise approach to enhance FECD management and ultimately improve patient outcomes. We thoroughly searched for FECD clinical trials and reviewed the study designs, methodologies, and outcomes of each trial conducted within the past decade. It is imperative for physicians to stay up-to-date with these cutting-edge treatment approaches.","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139449784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The mechanical theory of glaucoma in terms of prelaminar, laminar, and postlaminar factors 从层前、层中和层后因素看青光眼的力学理论

IF 1.1

Taiwan Journal of Ophthalmology Pub Date : 2023-12-21 DOI: 10.4103/tjo.tjo-d-23-00103

Syed Shoeb Ahmad

引用次数: 0

Advancing therapies for anterior segment developmental anomalies. 推进前段发育异常的治疗。

IF 1.1

Taiwan Journal of Ophthalmology Pub Date : 2023-12-20 eCollection Date: 2023-10-01 DOI: 10.4103/tjo.TJO-D-23-00167

Muralidhar Ramappa, Ken K Nischal

引用次数: 0

Clinical and diagnostic imaging profile of three anterior segment dysgenesis disorders presenting with infantile corneal opacities. 三种伴有婴幼儿角膜混浊的前节发育不良疾病的临床和影像诊断概况。

IF 1.1

Taiwan Journal of Ophthalmology Pub Date : 2023-12-20 eCollection Date: 2023-10-01 DOI: 10.4103/tjo.TJO-D-23-00134

Ananya Kaginalkar, Radhika Tandon, M Vanathi, Noopur Gupta, Viney Gupta, Seema Sen, Seema Kashyap, Arundhati Sharma

{"title":"Clinical and diagnostic imaging profile of three anterior segment dysgenesis disorders presenting with infantile corneal opacities.","authors":"Ananya Kaginalkar, Radhika Tandon, M Vanathi, Noopur Gupta, Viney Gupta, Seema Sen, Seema Kashyap, Arundhati Sharma","doi":"10.4103/tjo.TJO-D-23-00134","DOIUrl":"10.4103/tjo.TJO-D-23-00134","url":null,"abstract":"Purpose: To describe three anterior segment dysgenesis disorders with infantile corneal opacities, namely, congenital hereditary endothelial dystrophy (CHED), primary congenital glaucoma (PCG), and Peters anomaly (PA) in terms of clinical characteristics, histopathology, genetic association, and diagnostic imaging profiles using imaging modalities such as ultrasound biomicroscopy (UBM) and microscope-integrated intraoperative optical coherence tomography (i-OCT).Materials and methods: Seventy-four eyes with 22 eyes of CHED, 28 eyes of PA, and 24 eyes of PCG were clinically evaluated and underwent imaging using UBM and i-OCT. Corneal buttons of 16 operated patients underwent histopathological analysis, while genetic analysis was done in 23 patients using whole-exome sequencing.Results: Corneal diameters (CD) and UBM parameters like anterior chamber depth (ACD), iris thickness (IT), and ciliary body (CB) thickness revealed a statistically significant difference between the three categories. In PA, 9 eyes had a third rare phenotype with only a posterior corneal defect with no iris adhesions. Genetic mutations were seen in all tested patients with CHED, in 83.3% of patients with PCG, and in 80% of patients with the third type of PA. i-OCT helped in the characterization of corneal opacity, identification of posterior corneal defects, iridocorneal adhesions, and contour of Descemet's membrane.Conclusion: Overlapping phenotypes of the above disorders cause a diagnostic dilemma and parameters like CDs, UBM ACD, IT, and CB thickness help differentiate between them. i-OCT can help in classifying the diseases in a high resolution, non-contact manner, and can better delineate corneal characteristics. The rare third type of PA phenotype may have a genetic association.","PeriodicalId":44978,"journal":{"name":"Taiwan Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10798392/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139513994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Duane syndrome: An overview on the current management. 杜安综合征：当前管理概述。

IF 1.1

Taiwan Journal of Ophthalmology Pub Date : 2023-12-20 eCollection Date: 2023-10-01 DOI: 10.4103/tjo.TJO-D-23-00078

Priyanka Prasad, Abhyuday Saxena, Rohit Saxena

引用次数: 0